Recombinant human interleukin-2
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Recombinant human interleukin-2, covering 2017-03-03 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2 [EARLY_Phase 1]